<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2025-06-30</publicationDate>
    
        <volume>18</volume>
        <issue>2</issue>

 
    <startPage>1499</startPage>
    <endPage>1511</endPage>

	 
      <doi>10.13005/bpj/3188</doi>
        <publisherRecordId>65716</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Antidiabetic and Anti-inflammatory Properties of N-Phenyl Piperazine Derivatives through In Vitro Evaluations and Molecular Docking Studies</title>

    <authors>
	 


      <author>
       <name>Jayaprakash Thirunavukarasu </name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Abdul Rahim Shajahan</name>


		
	<affiliationId>1</affiliationId>

      </author>
    

	

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of  Chemistry, B S Abdur Rahman Crescent Institute of Science and Technology, Vandalur, Chennai, Tamil nadu, India.</affiliationName>
    

		
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">N-phenyl Piperazine derivatives have increasingly been recognized for their profound medicinal properties. This study embarks on the synthesis and study of such derivatives, specifically focusing on their <em>in vitro </em>α-amylase inhibitory and anti-inflammatory potential. Employing in silico molecular docking strategies, we assessed the interactions of these derivatives with the α-amylase enzyme (1HNY.pdb). Compounds P6, P7, and P22 emerged with commendable docking scores  as -8.44, -8.37, and -8.49 kcal/mol, prompting their synthesis and assessment of in vitro α-amylase activity assessment. Among the studied compounds, P7 demonstrated robust inhibitory effects against both α- amylase and inflammation. Complementing the docking studies, this comprehensive investigation underscores the potential of N-phenyl Piperazine derivatives as potent bioactive molecules.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol18no2/antidiabetic-and-anti-inflammatory-properties-of-n-phenyl-piperazine-derivatives-through-in-vitro-evaluations-and-molecular-docking-studies/</fullTextUrl>

<keywords language="eng">

      
        <keyword>Amylase inhibitor</keyword>
      

      
        <keyword> Anti-diabetic activity</keyword>
      

      
        <keyword> Anti-inflammatory</keyword>
      

      
        <keyword> N-phenyl piperazines</keyword>
      
</keywords>
  </record>
</records>